论文信息 - A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas - 字舞流文

A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas

Michael L. Wang | Y. Oki | L. Kwak | L. Fayad | J. Westin | R. Piekarz | R. Davis | H. Lee | M. Fanale | F. Hagemeister | L. Nastoupil | N. Fowler | P. Strati | Charnelle E. Ruben | Emily T Wesson